Is the population level of anxiety and depression associated with mortality? Data from the ESSE-RF study
https://doi.org/10.15829/1728-8800-2021-3009
Abstract
Aim. To study the associations of subclinical and clinical anxiety and depression, assesed by the Hospital Anxiety and Depression Scale (HADS), ≥8 points and ≥11 points, respectively, with all-cause mortality and cardiovascular mortality, as well as with the total number of nonfatal cardiovascular events (CVEs) in Russia.
Material and methods. The study included male and female population aged 25-64 years from the Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study who signed an informed consent. The study included 16941 people (men, 6811 (40,2%)). To assess the anxiety and depression, HADS scale was used. The statistical analysis included individuals with subclinical/clinical (HADS ≥8) and clinical (HADS ≥11) anxiety and depression (HADS-A and HADS-D). The median of prospective follow-up was 5,5 years (from 2012 to 2019). The composite endpoint (CE) (cardiovascular death and nonfatal CVE occurred in 268 (4,2%) men and 203 (2,1%) women, while all-cause — in 220 (3,2%) men and 152 (1,5%) women.
Results. The results obtained showed that the survival rate of men and women with varying degrees of anxiety (HADS-A ≥8 and ≥11) was associated with all-cause mortality and CE in women. However, this relationship has not been confirmed in multivariate models. In the multivariate Cox proportional hazards model 1 (M1), a significant association of depression with all-cause mortality in women was revealed — HADS-D ≥8: relative risk (RR), 2,22; 95% confidence interval (CI): 1,56-3,15 and ≥11: RR, 2,43; 95% CI: 1,65-3,59 (p<0,005), as well as in men — HADS-D ≥8: RR, 1,51; 95% CI: 1,10-2,08 (p=0,01). In model 2 (M2), when added to M1 as a predictor of prior cardiovascular disease (≥3), depression was significantly associated with all-cause mortality only in women — HADS-D ≥8: RR, 2,23; 95% CI: 1,53-3,24 (p<0,005); HADS-D ≥11: RR, 2,61; 95% CI: 1,74-3,92 (p=0,01). In addition, only in women, subclinical/clinical depression (HADS-D ≥8) was significantly associated with fatal and non-fatal CVE — HADS-D ≥8: RR, 1,46; 95% CI: 1,08-1,98 (p=0,02).
Conclusion. Depression (HADS-D ≥8 and ≥11) in Russian women was significantly associated with all-cause mortality and CE (HADS-D ≥8). In men, depression (HADS-D ≥8) was significantly associated with allcause mortality when only conventional risk factors were included in the model, without taking into account prior cardiovascular disease. Anxiety in multivariate models was not associated with all-cause mortality and CE in both sex groups.
About the Authors
S. E. EvstifeevaRussian Federation
Moscow.
Tel.: +7 (916) 780-42-27
S. A. Shalnova
Russian Federation
Moscow.
Yu. K. Makarova
Russian Federation
Moscow.
E. B. Yarovaya
Russian Federation
Moscow.
Yu. A. Balanova
Russian Federation
Moscow.
A. E. Imaeva
Russian Federation
Moscow.
A. V. Kapustina
Russian Federation
Moscow.
G. A. Muromtseva
Russian Federation
Moscow.
S. A. Maksimov
Russian Federation
Moscow.
N. S. Karamnova
Russian Federation
Moscow.
G. V. Artamonova
Russian Federation
Kemerovo.
O. A. Belova
Russian Federation
Ivanovo.
Yu. I. Grinshtein
Russian Federation
Krasnoyarsk.
М. M. Petrova
Russian Federation
Krasnoyarsk.
D. V. Duplyakov
Russian Federation
Samara.
A. Yu. Efanov
Russian Federation
Tyumen.
N. V. Kulakova
Russian Federation
Vladivostok.
R. A. Libis
Russian Federation
Orenburg.
T. M. Chernykh
Russian Federation
Voronezh.
O. P. Rotar
Russian Federation
St. Petersburg.
I. A. Trubacheva
Russian Federation
Tomsk.
A. A. Shabunova
Russian Federation
Vologda.
A. O. Konradi
Russian Federation
St. Petersburg.
S. A. Boytsov
Russian Federation
Moscow.
O. M. Drapkina
Russian Federation
Moscow.
References
1. Global health estimates 2015: disease burden by cause, age, sex, by country and by region, 2OOO-2015. Geneva. World Health Organization 2016 [Электронный ресурс] URL: http://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html. (дата обращения 18 июня 2021)
2. Mental health. Information sheet 3 October 2019. (In Russ.)
3. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789-858. doi:10.1016/S0140-6736(19)31047-5.
4. Data and statistics. Geneva. World Health Organization. (In Russ.) Данные и статистика. Geneva. World Health Organization. [Электронный ресурс] URL: http://www.euro.who.int/ru/countries/russian-federation/data-and-statistics/infographic-depression-in-the-russian-federation-2017. (дата обращения 18 июня 2021)
5. Shalnova SA, Evstifeeva SE, Deev AD, et al., on behalf of the participants of the ESSE-RF study. The prevalence of anxiety and depression in different regions of the Russian Federation and its association with sociodemographic factors (according to the data of the ESSE-RF study). Russ J Therapeutic archive. 2014;12:52-9. (In Russ.)
6. Jarvis E. On the comparative liability of males and females to insanity: and their comparative curability and mortality when insane. Am J of Insanity. 1850;7:142-71. [Электронный ресурс] URL: https://archive.org/details/2558059R.nlm.nih.gov. (дата обращения 19 июня 2021).
7. Kish L. Survey Sampling. New York: John Wiley and Sons, 1965. ISBN: 0-471-48900 Х.
8. Nauchno-organizatsionnyTkomitet. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Profilakticheskaya Meditsina. 2013;16(6):25-34. (In Russ.)
9. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand. 1983;67:361-70.
10. Andryushchenko AV, Drobizhev MYu, Dobrovolskiy AV. Comparative assessment of the CES-D, BDE and HADS (d) scales in the diagnosis of depression in general medical practice. Jur Neur and Psychiatrist. 2003;5:11-7. (In Russ.)
11. Schulz R, Drayer RA, Rollma BL. Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry. 2002;52(3):205-25. doi:10.1016/s0006-3223(02)01423-3.
12. Oganov RG, Pogosova GV, Koltunov IE, et al. Depressive symptoms worsen cardiovascular prognosis and shortens length of life in patients with arterial hypertension and ischemic heart disease. Russ J Cardiology. 2011;2:59-66. (In Russ.)
13. Belyalov FI. Mental disorders in the practice of a therapist. Irkutsk. RIO IGMAPO. 2014; 341 р. (In Russ.)
14. Gafarov VV, Gromova EA, Gagulin IV, et al. Gender characteristics of the risk of developing cardiovascular diseases in the population with symptoms of depression in Siberia (WHO program “MONICA-psychosocial”). Russ J Therapeutic Archive. 2017;89(9):60-7. (In Russ.)
15. Gilman SE, Sucha E, Kingsbury M, et al. Depression and mortality in a longitudinal study: 1952-2011. CMAJ. 2017;189:E1304-10. doi:10.1503/cmaj.170125.
16. Hannah MK, Batty GD, Benzeval M. Common mental disorders and mortality in the West of Scotland Twenty-07 Study: comparing the General Health Questionnaire and the Hospital Anxiety and Depression Scale. J Epidemiol Community Health. 2013;67:558-63. doi:10.1136/jech-2012-201927.
17. 17 Mykletun A, Bjerkeset O, lllverland S, et al. Levels of anxiety and depression as predictors of mortality: the HUNT study. BJ Psych. 2009;195:118-25. doi:10.1192/bjp.bp.108.054866.
18. Machado MO, Veronese N, Sanches M, et al. The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and metaanalyses. BMC Med. 2018;16:112. doi:10.1186/s12916-018-1101-z.
19. Meng R, Yu C, Liu N, et al. Association between Depression and All-cause and Cardiovascular Mortality in Chinese Adults. JAMA. 2020;3(2):e1921043. doi:10.1001/jamanetworkopen.2019.21043.
Supplementary files
Review
For citations:
Evstifeeva S.E., Shalnova S.A., Makarova Yu.K., Yarovaya E.B., Balanova Yu.A., Imaeva A.E., Kapustina A.V., Muromtseva G.A., Maksimov S.A., Karamnova N.S., Artamonova G.V., Belova O.A., Grinshtein Yu.I., Petrova М.M., Duplyakov D.V., Efanov A.Yu., Kulakova N.V., Libis R.A., Chernykh T.M., Rotar O.P., Trubacheva I.A., Shabunova A.A., Konradi A.O., Boytsov S.A., Drapkina O.M. Is the population level of anxiety and depression associated with mortality? Data from the ESSE-RF study. Cardiovascular Therapy and Prevention. 2021;20(5):3009. (In Russ.) https://doi.org/10.15829/1728-8800-2021-3009